271 related articles for article (PubMed ID: 24117238)
21. The co-chaperone Cdc37 regulates the rabies virus phosphoprotein stability by targeting to Hsp90AA1 machinery.
Xu Y; Liu F; Liu J; Wang D; Yan Y; Ji S; Zan J; Zhou J
Sci Rep; 2016 Jun; 6():27123. PubMed ID: 27251758
[TBL] [Abstract][Full Text] [Related]
22. Regulation of Hsp90 ATPase activity by the co-chaperone Cdc37p/p50cdc37.
Siligardi G; Panaretou B; Meyer P; Singh S; Woolfson DN; Piper PW; Pearl LH; Prodromou C
J Biol Chem; 2002 Jun; 277(23):20151-9. PubMed ID: 11916974
[TBL] [Abstract][Full Text] [Related]
23. Hsp90 C-terminal inhibitors exhibit antimigratory activity by disrupting the Hsp90α/Aha1 complex in PC3-MM2 cells.
Ghosh S; Shinogle HE; Garg G; Vielhauer GA; Holzbeierlein JM; Dobrowsky RT; Blagg BS
ACS Chem Biol; 2015 Feb; 10(2):577-90. PubMed ID: 25402753
[TBL] [Abstract][Full Text] [Related]
24. Blocking the chaperone kinome pathway: mechanistic insights into a novel dual inhibition approach for supra-additive suppression of malignant tumors.
Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D
Biochem Biophys Res Commun; 2011 Jan; 404(1):498-503. PubMed ID: 21144839
[TBL] [Abstract][Full Text] [Related]
25. Hsp90 provides a platform for kinase dephosphorylation by PP5.
Jaime-Garza M; Nowotny CA; Coutandin D; Wang F; Tabios M; Agard DA
Nat Commun; 2023 Apr; 14(1):2197. PubMed ID: 37069154
[TBL] [Abstract][Full Text] [Related]
26. Simvastatin functions as a heat shock protein 90 inhibitor against triple-negative breast cancer.
Kou X; Jiang X; Liu H; Wang X; Sun F; Han J; Fan J; Feng G; Lin Z; Jiang L; Yang Y
Cancer Sci; 2018 Oct; 109(10):3272-3284. PubMed ID: 30039622
[TBL] [Abstract][Full Text] [Related]
27. Targeting the HSP90-CDC37-kinase chaperone cycle: A promising therapeutic strategy for cancer.
Wang L; Zhang Q; You Q
Med Res Rev; 2022 Jan; 42(1):156-182. PubMed ID: 33846988
[TBL] [Abstract][Full Text] [Related]
28. Silencing of HSP90 cochaperone AHA1 expression decreases client protein activation and increases cellular sensitivity to the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin.
Holmes JL; Sharp SY; Hobbs S; Workman P
Cancer Res; 2008 Feb; 68(4):1188-97. PubMed ID: 18281495
[TBL] [Abstract][Full Text] [Related]
29. Detecting Posttranslational Modifications of Hsp90 Isoforms.
Sager RA; Backe SJ; Neckers L; Woodford MR; Mollapour M
Methods Mol Biol; 2023; 2693():125-139. PubMed ID: 37540432
[TBL] [Abstract][Full Text] [Related]
30. The Activity and Stability of p56Lck and TCR Signaling Do Not Depend on the Co-Chaperone Cdc37.
Kowallik S; Kritikos A; Kästle M; Thurm C; Schraven B; Simeoni L
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374422
[TBL] [Abstract][Full Text] [Related]
31. Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function.
Basso AD; Solit DB; Chiosis G; Giri B; Tsichlis P; Rosen N
J Biol Chem; 2002 Oct; 277(42):39858-66. PubMed ID: 12176997
[TBL] [Abstract][Full Text] [Related]
32. Post-translational Regulation of FNIP1 Creates a Rheostat for the Molecular Chaperone Hsp90.
Sager RA; Woodford MR; Backe SJ; Makedon AM; Baker-Williams AJ; DiGregorio BT; Loiselle DR; Haystead TA; Zachara NE; Prodromou C; Bourboulia D; Schmidt LS; Linehan WM; Bratslavsky G; Mollapour M
Cell Rep; 2019 Jan; 26(5):1344-1356.e5. PubMed ID: 30699359
[TBL] [Abstract][Full Text] [Related]
33. The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.
Jinwal UK; Trotter JH; Abisambra JF; Koren J; Lawson LY; Vestal GD; O'Leary JC; Johnson AG; Jin Y; Jones JR; Li Q; Weeber EJ; Dickey CA
J Biol Chem; 2011 May; 286(19):16976-83. PubMed ID: 21367866
[TBL] [Abstract][Full Text] [Related]
34. [Molecular chaperone HSP90 as a novel target for cancer chemotherapy].
Miyata Y
Nihon Yakurigaku Zasshi; 2003 Jan; 121(1):33-42. PubMed ID: 12617036
[TBL] [Abstract][Full Text] [Related]
35. The effect of celastrol, a triterpene with antitumorigenic activity, on conformational and functional aspects of the human 90kDa heat shock protein Hsp90α, a chaperone implicated in the stabilization of the tumor phenotype.
Zanphorlin LM; Alves FR; Ramos CH
Biochim Biophys Acta; 2014 Oct; 1840(10):3145-52. PubMed ID: 24954307
[TBL] [Abstract][Full Text] [Related]
36. Hsp90α regulates ATM and NBN functions in sensing and repair of DNA double-strand breaks.
Pennisi R; Antoccia A; Leone S; Ascenzi P; di Masi A
FEBS J; 2017 Aug; 284(15):2378-2395. PubMed ID: 28631426
[TBL] [Abstract][Full Text] [Related]
37. HSP90-CDC37-PP5 forms a structural platform for kinase dephosphorylation.
Oberoi J; Guiu XA; Outwin EA; Schellenberger P; Roumeliotis TI; Choudhary JS; Pearl LH
Nat Commun; 2022 Nov; 13(1):7343. PubMed ID: 36446791
[TBL] [Abstract][Full Text] [Related]
38. Discovery of a covalent inhibitor of heat shock protein 90 with antitumor activity that blocks the co-chaperone binding via C-terminal modification.
Li L; Chen N; Xia D; Xu S; Dai W; Tong Y; Wang L; Jiang Z; You Q; Xu X
Cell Chem Biol; 2021 Oct; 28(10):1446-1459.e6. PubMed ID: 33932325
[TBL] [Abstract][Full Text] [Related]
39. Stimulation of the weak ATPase activity of human hsp90 by a client protein.
McLaughlin SH; Smith HW; Jackson SE
J Mol Biol; 2002 Jan; 315(4):787-98. PubMed ID: 11812147
[TBL] [Abstract][Full Text] [Related]
40. c-Abl Mediated Tyrosine Phosphorylation of Aha1 Activates Its Co-chaperone Function in Cancer Cells.
Dunn DM; Woodford MR; Truman AW; Jensen SM; Schulman J; Caza T; Remillard TC; Loiselle D; Wolfgeher D; Blagg BS; Franco L; Haystead TA; Daturpalli S; Mayer MP; Trepel JB; Morgan RM; Prodromou C; Kron SJ; Panaretou B; Stetler-Stevenson WG; Landas SK; Neckers L; Bratslavsky G; Bourboulia D; Mollapour M
Cell Rep; 2015 Aug; 12(6):1006-18. PubMed ID: 26235616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
